• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

严重急性呼吸综合征冠状病毒 2 感染危重症患者静脉血栓栓塞事件的患病率和危险因素:一项前瞻性观察研究。

Prevalence and risk factors for venous thromboembolic events in critically ill patients with SARS-CoV-2 infection: a prospective observational study.

机构信息

Department of Intensive Care Medicine, Ente Ospedaliero Cantonale, Bellinzona, Switzerland -

Department of Intensive Care Medicine, Ente Ospedaliero Cantonale, Bellinzona, Switzerland.

出版信息

Minerva Anestesiol. 2021 Dec;87(12):1330-1337. doi: 10.23736/S0375-9393.21.15510-5. Epub 2021 Oct 11.

DOI:10.23736/S0375-9393.21.15510-5
PMID:34633166
Abstract

BACKGROUND

The majority of prevalence studies on deep vein thrombosis (DVT) in severe COVID-19 patients are retrospective with DVT assessment based on clinical suspicion. Our aim was to prospectively and systematically estimate the occurrence of DVT in critically-ill mechanically-ventilated patients, and to identify potential risk factors for DVT occurrence and mortality.

METHODS

All patients with COVID-19 admitted to our 45 beds in the Intensive Care Unit (ICU) between March 6, 2020, and April 18, 2020, requiring invasive ventilatory support were daily screened for DVT with lower extremities and jugular veins ultrasonography. Univariate and multivariable logistic regression models were performed in order to identify predictors of DVT and mortality.

RESULTS

Seventy-six patients were included in the final analysis (56 men, mean age 67 years, median SOFA=7 points, median SAPS II=41 points, median PaO2/Fi02=10.8 kPa). The period prevalence of DVT was 40.8%. Thirty-one DVTs were diagnosed. Twenty-five DVTs (80.6% of total DVTs) were catheter-related, mainly in the jugular veins. Twenty-six DVTs (83.9%) occurred in patients receiving enhanced antithrombotic prophylaxis. No independent variable was predictive of DVT occurrence. Twenty-eight patients (36.8%) died during the ICU stay. Age and SOFA score were independently associated with mortality.

CONCLUSIONS

A high number of critically-ill mechanically-ventilated COVID-19 patients developed a DVT. The majority of DVTs were catheter-related and occurred under intensive prophylactic anticoagulation. Routine ultrasound of the jugular veins should be suggested in this patient population, and in particular in presence of a central venous catheter.

摘要

背景

大多数关于严重 COVID-19 患者深静脉血栓形成(DVT)的流行率研究都是回顾性的,DVT 的评估基于临床怀疑。我们的目的是前瞻性和系统地估计重症机械通气患者中 DVT 的发生,并确定 DVT 发生和死亡率的潜在危险因素。

方法

2020 年 3 月 6 日至 4 月 18 日期间,我们对入住重症监护病房(ICU)的 45 张床位的所有 COVID-19 患者进行了每日筛查,使用下肢和颈静脉超声检查 DVT。进行单变量和多变量逻辑回归模型,以确定 DVT 和死亡率的预测因素。

结果

76 例患者纳入最终分析(56 例男性,平均年龄 67 岁,中位数 SOFA=7 分,中位数 SAPS II=41 分,中位数 PaO2/Fi02=10.8 kPa)。DVT 的流行率为 40.8%。诊断出 31 例 DVT。25 例 DVT(总 DVT 的 80.6%)与导管相关,主要发生在颈静脉。26 例 DVT(83.9%)发生在接受增强抗血栓预防的患者中。没有独立变量可预测 DVT 的发生。28 例患者(36.8%)在 ICU 期间死亡。年龄和 SOFA 评分与死亡率独立相关。

结论

大量重症机械通气的 COVID-19 患者发生 DVT。大多数 DVT 与导管有关,且在强化预防性抗凝治疗下发生。建议对该患者人群,特别是在存在中心静脉导管的情况下,对颈静脉进行常规超声检查。

相似文献

1
Prevalence and risk factors for venous thromboembolic events in critically ill patients with SARS-CoV-2 infection: a prospective observational study.严重急性呼吸综合征冠状病毒 2 感染危重症患者静脉血栓栓塞事件的患病率和危险因素:一项前瞻性观察研究。
Minerva Anestesiol. 2021 Dec;87(12):1330-1337. doi: 10.23736/S0375-9393.21.15510-5. Epub 2021 Oct 11.
2
Prevalence and Predictors of Deep Vein Thrombosis in Critically Ill Medical Patients Who Underwent Diagnostic Duplex Ultrasonography.接受诊断性双功能超声检查的危重症医学患者中深静脉血栓形成的发生率及预测因素。
J Intensive Care Med. 2020 Oct;35(10):1062-1066. doi: 10.1177/0885066618813300. Epub 2018 Nov 19.
3
Deep vein thrombosis in hospitalized patients with coronavirus disease 2019.COVID-19 住院患者的深静脉血栓形成。
J Vasc Surg Venous Lymphat Disord. 2021 May;9(3):597-604. doi: 10.1016/j.jvsv.2020.09.010. Epub 2020 Oct 8.
4
Incidence of deep venous thrombosis in COVID-19 critically ill patients treated with intermediate-dose of heparin for thromboprophylaxis: The COVIDOP-DVT observational study.COVID-19 危重症患者接受中等剂量肝素预防血栓形成治疗后的深静脉血栓发生率:COVIDOP-DVT 观察性研究。
Vascular. 2024 Oct;32(5):1099-1106. doi: 10.1177/17085381231165083. Epub 2023 Apr 3.
5
Incidence of deep venous thrombosis in COVID-19 hospitalized patients during the first peak of the Italian outbreak.意大利疫情首次高峰期间住院 COVID-19 患者深静脉血栓形成的发生率。
Phlebology. 2021 Jun;36(5):375-383. doi: 10.1177/0268355520975592. Epub 2020 Nov 26.
6
Deep vein thrombosis in noncritically ill patients with coronavirus disease 2019 pneumonia: deep vein thrombosis in nonintensive care unit patients.COVID-19 肺炎非危重症患者的深静脉血栓形成:非重症监护病房患者的深静脉血栓形成。
J Vasc Surg Venous Lymphat Disord. 2021 May;9(3):592-596. doi: 10.1016/j.jvsv.2020.08.028. Epub 2020 Sep 7.
7
DVT incidence and risk factors in critically ill patients with COVID-19.COVID-19 重症患者的 DVT 发生率和危险因素。
J Thromb Thrombolysis. 2021 Jan;51(1):33-39. doi: 10.1007/s11239-020-02181-w.
8
Characteristics of deep vein thrombosis in the critically ill COVID-19 patient - an observational cohort study with Doppler ultrasound measurements.危重症 COVID-19 患者深静脉血栓形成的特征 - 一项使用多普勒超声测量的观察性队列研究。
Eur Rev Med Pharmacol Sci. 2022 Jan;26(2):686-694. doi: 10.26355/eurrev_202201_27895.
9
SOFA Score as a Reliable Tool to Detect High Risk for Venous Thrombosis in Patients With Critical Stage SARS-CoV-2.序贯器官衰竭评估(SOFA)评分作为检测重症新型冠状病毒肺炎患者静脉血栓形成高风险的可靠工具
Front Cardiovasc Med. 2021 Oct 28;8:729298. doi: 10.3389/fcvm.2021.729298. eCollection 2021.
10
Venous thromboembolism and bleeding in critically ill patients with severe renal insufficiency receiving dalteparin thromboprophylaxis: prevalence, incidence and risk factors.接受达肝素血栓预防的严重肾功能不全重症患者的静脉血栓栓塞和出血:患病率、发病率及危险因素
Crit Care. 2008;12(2):R32. doi: 10.1186/cc6810. Epub 2008 Mar 3.